Apixaban, rivaroxaban and dabigatran appeared to have similar efficacy for secondary stroke prevention in patients with atrial fibrillation, according to a new analysis.
methods of stroke prevention, adjusted-dose oral vitamin K antagonist (VKA) therapy, and management of bleeding on oral anticoagulation, among other topics. ... When oral anticoagulation is recommended or suggested, the guidelines suggest using a novel
practical start-up and follow-up plans for patients taking new oral anticoagulants,. ... comparison of new anticoagulants and vitamin K antagonists in patients with AF and a malignancy.
Singer. Stopping a bleed in a patient on anticoagulation is only part of the battle. ... California San Francisco and chief of the anticoagulation and thrombosis services at the San Francisco VA Hospital.
Apixaban linked to lower risk of serious bleeding compared to warfarin in patients with or without afib
A recent comparison of anticoagulants in a real-world population found apixaban to be the safest drug, with reduced risks of major, intracranial, and gastrointestinal bleeding compared to warfarin. ... Using data from two U.K. primary care databases,
The findings in patients with intracerebral hemorrhage suggest that non–vitamin K antagonist oral anticoagulants may be better than warfarin for patients requiring an anticoagulant with or without concomitant antiplatelet therapy, ... To the authors'
30, 2010. Patients were assigned to prophylactic anticoagulation, mechanical devices, both, or neither, based on clinical judgment. ... Researchers compared outcomes for those on prophylactic anticoagulation versus mechanical devices in a separate paired
Medical management for NSTEMI includes aspirin, β-blockers, nitrates, and anticoagulants. Recent randomized trials have shown that full-dose low-molecular-weight heparin is more effective than full-dose unfractionated heparin ... The advantages of
Anticoagulation was associated with a significantly increased risk of bleeding in patients with acute pulmonary disease (OR, 1.72; 95% CI, 1.23 to 2.39). ... The study was limited by inability to determine whether AF was transient, the overall low
Adding aspirin or NSAID to anticoagulant doubles bleeding risk, guidelines on Clostridium difficile and surgical-site infections, and more. ... The researchers looked at days of aspirin or NSAID use while patients were on one of the anticoagulants and